# APITBIO CO.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apitbio-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.apitbio.com
- Total disclosed funding: $13M
- Latest round: Series A (Feb 8, 2021)
- Investors on record: 9

## About

Based in Seoul, South Korea, and founded in 2018 by CEO Seon-Joo Yoon, APITBIO CO., LTD. provides a platform to research and develop antibody-based therapeutics. In February 2021, Apitbio Co., Ltd. raised KRW 14 billion in series A funding from UTC Investment, LSK Investment, KDB Capital, Mirae Equity Partners, Laguna Investment, Hyundai Technology Investment, KB Securities, Kolon Investment, and Shinhan Venture Investment.

APITBIO develops antibody-based innovative anticancer drugs such as monoclonal antibodies and double antibodies through research and develops innovative antibody therapeutics from screening and discovery to optimization and production, thus helping hospitals treat the unmet medical needs of patients. The company uses a one-stop system antibody library to generate candidate antibodies optimized for new targets for generating antibodies in sufficient quantities to test for preliminary toxicity in primates. As of April 2023, the firm is in phase 1 of developing a monoclonal, bispecific, and CAR-T pipeline.

## Funding rounds

- Series A, Feb 8, 2021, $13M — Hyundai Venture Investment, Shinhan Venture Investment, KDB Capital, Kolon Investment, UTC Investment, KB Securities, LSK Investment, Laguna Investment, Mirae Equity Partners

## Investors

- Hyundai Venture Investment (https://capitalatlas.ai/funds/hyundai-venture-investment) — Series A
- Shinhan Venture Investment (https://capitalatlas.ai/funds/shinhan-venture-investment) — Series A
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series A
- Kolon Investment (https://capitalatlas.ai/funds/kolon-investment) — Series A
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series A
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series A
- Laguna Investment (https://capitalatlas.ai/funds/laguna-investment) — Series A
- Mirae Equity Partners (https://capitalatlas.ai/funds/mirae-equity-partners) — Series A